PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study

Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006

(2014) Ayako Nakajima et al.   Modern Rheumatology

Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population

(2012) Yukinori Okada et al.   NATURE GENETICS

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Polymorphisms in peptidylarginine deiminase (PADI) associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis

(2012) Chun Lai Too et al.   ARTHRITIS RESEARCH & THERAPY

Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA Shared Loci

(2011) Alexandra Zhernakova et al.   PLoS Genetics

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

(2010) Eli A Stahl et al.   NATURE GENETICS

Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis

(2010) Kumi Shidara et al.   RHEUMATOLOGY INTERNATIONAL

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA

(2010) A Nakajima et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study

(2010) So-Young Bang et al.   ARTHRITIS RESEARCH & THERAPY

Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese

(2009) K Nishimoto et al.   ANNALS OF THE RHEUMATIC DISEASES

PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population

(2009) M. L. Burr et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment

(2009) D. Aletaha et al.   ARTHRITIS AND RHEUMATISM

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis

(2008) B Hoppe et al.   ANNALS OF THE RHEUMATIC DISEASES

Association ofSTAT4with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population

(2008) Shu Kobayashi et al.   ARTHRITIS AND RHEUMATISM

Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis

(2008) Michelle L. Harris et al.   ARTHRITIS AND RHEUMATISM

Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies

(2008) J. K. de Vries-Bouwstra et al.   ARTHRITIS AND RHEUMATISM

Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis

(2008) Adriana Rojas-Villarraga et al.   JOURNAL OF AUTOIMMUNITY

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability

(2007) E Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients

(2007) S. Tsukahara et al.   RHEUMATOLOGY